Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 7 EP applications Nicholas James Finnie has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after January 16, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12709383

METHOD FOR DETECTING PARVOVIRUS ANTIGEN

IPC classification:
G01N 33/569
Applicant:
University of Regensburg (Universit├Ąt Regensburg)
Applicant:
Novartis AG
Agent:
Carpmaels & Ransford LLP
Agent:
Nicholas James Finnie, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14160481

Alphavirus vectors for RSV and PIV vaccines

IPC classification:
A61K 39/00, A61K 39/02, A61K 39/12, A61K 39/145, A61K 39/155, A61K 39/215, A61K 39/295, C12N 15/86
Applicant:
Novartis Vaccines and Diagnostics Inc.
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Agent:
Nicholas James Finnie, Novartis Pharma AG
Status:
EXAMINATION IN PROGRESS
EP14189933

Alphavirus vectors for influenza virus vaccines

IPC classification:
A61K 39/00, A61K 39/02, A61K 39/12, A61K 39/145, A61K 39/155, A61K 39/215, A61K 39/295, C12N 15/86
Applicant:
Novartis Vaccines and Diagnostics Inc.
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Agent:
Nicholas James Finnie, Novartis Pharma AG
Status:
GRANT OF PATENT INTENDED
EP14700356

INFLUENZA VIRUS IMMUNOGENIC COMPOSITIONS AND USES THEREOF

IPC classification:
A61K 39/145, C12N 7/04, C12N 15/867
Applicant:
Novartis AG
Agent:
Carpmaels & Ransford LLP
Agent:
Nicholas James Finnie, Novartis Pharma AG
Status:
GRANT OF PATENT INTENDED
EP14736835

ROTAVIRUS PARTICLES WITH CHIMERIC SURFACE PROTEINS

IPC classification:
C07K 14/14
Applicant:
Novartis AG
Applicant:
Children's Medical Center Corporation
Applicant:
Brandeis University
Agent:
Nicholas James Finnie, Novartis Pharma AG
Status:
GRANT OF PATENT INTENDED
EP14798760

REMOVAL OF RESIDUAL CELL CULTURE IMPURITIES

IPC classification:
A61K 39/00, C07K 1/18
Applicant:
Novartis AG
Agent:
Florian Bielefeldt, Novartis AG
Agent:
Nicholas James Finnie, Novartis International AG
Status:
EXAMINATION REQUESTED
EP15805141

MANUFACTURE OF SURFACTANT-CONTAINING COMPOSITIONS

IPC classification:
A61K 9/107, A61K 47/26
Applicant:
Novartis AG
Agent:
Nicholas James Finnie, Novartis International AG
Status:
Request for examination was made

Please Sign in to use this feature